Clinical Trial Update: Effect of ZILRETTA Versus CELESTONE on Quality of Life, Pain, Neuromuscular Function, and Physical Performance [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ZILRETTA to CELESTONE in knee osteoarthritis assessing quality of life, pain, neuromuscular function, and physical performance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis Knee

Drugs mentioned

• CELESTONE (celecoxib)
• ZILRETTA (Triamcinolone acetonide extended-release injectable suspension)

Snippet

Sponsor: ROC Foundation | Conditions: Osteoarthritis, Knee | Phase 4 | Status: COMPLETED